🔥🐔 BizChicken 🐔🔥
Companies Similar to Verrica Pharmaceuticals Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Arcutis Biotherapeutics, Inc.
ARQ-151
Arcutis Biotherapeutics, Inc. is a biopharmaceutical company developing and commercializing treatments for dermatological diseases, including plaque psoriasis, atopic dermatitis, seborrheic dermatitis, scalp psoriasis, hand eczema, vitiligo, and alopecia areata.
About | ESG | About | About | About | Contact | Careers | About | Jobs | Jobs | About | About | About | About
Symbol: ARQT
Recent Price: $14.20
Industry: Biotechnology
CEO: Mr. Todd Franklin Watanabe M.A.
Sector: Healthcare
Employees: 296
Address: 3027 Townsgate Road, Westlake Village, CA 91361
Phone: 805 418 5006
Last updated: 2024-12-31
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Vera Therapeutics, Inc.
atacicept
Vera Therapeutics, Inc. is a clinical stage biotechnology company focusing on developing and commercializing treatments for serious immunological diseases, including atacicept for immunoglobulin A nephropathy and MAU868 for BK viremia infections.
Careers | About | About | About | About | Contact | Careers | Careers | Jobs | About | About | Jobs | Careers
Symbol: VERA
Recent Price: $42.06
Industry: Biotechnology
CEO: Dr. Marshall W. Fordyce M.D.
Sector: Healthcare
Employees: 72
Address: 8000 Marina Boulevard, Brisbane, CA 94005
Phone: 650 770 0077
Last updated: 2024-12-31
Veru Inc.
FC2 female condom
Veru Inc. is an oncology biopharmaceutical company focused on developing medicines for cancer management. The company offers commercial products and has several development drug candidates in clinical trials.
Symbol: VERU
Recent Price: $0.64
Industry: Biotechnology
CEO: Dr. Mitchell S. Steiner F.A.C.S., M.D.
Sector: Healthcare
Employees: 189
Address: 48 NW 25th Street, Miami, FL 33127
Phone: 305 509 6897
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Cumberland Pharmaceuticals Inc.
Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex
Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.
Symbol: CPIX
Recent Price: $2.42
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. A. J. Kazimi MBA
Sector: Healthcare
Employees: 91
Address: 2525 West End Avenue, Nashville, TN 37203
Phone: 615 255 0068
Last updated: 2024-12-31
Dermata Therapeutics, Inc.
DMT310
Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development and commercialization of pharmaceutical candidates for treating medical and aesthetic skin conditions. The company focuses on products such as DMT310 for acne, rosacea, and psoriasis, and DMT410 for hyperhidrosis and aesthetic conditions.
Symbol: DRMA
Recent Price: $1.34
Industry: Biotechnology
CEO: Mr. Gerald T. Proehl
Sector: Healthcare
Employees: 8
Address: 3525 Del Mar Heights Road, San Diego, CA 92130
Phone: 858 800 2543
Last updated: 2024-12-31
Vincerx Pharma, Inc.
VIP152
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.
Symbol: VINC
Recent Price: $0.33
Industry: Biotechnology
CEO: Dr. Ahmed M. Hamdy M.D.
Sector: Healthcare
Employees: 42
Address: 260 Sheridan Avenue, Palo Alto, CA 94306
Phone: 650 800 6676
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Verrica Pharmaceuticals Inc.
VP-102, VP-103
Verrica Pharmaceuticals Inc. develops and commercializes treatments for skin diseases in the United States, including products for molluscum contagiosum and warts. The company collaborates with Torii Pharmaceutical Co., Ltd., and Lytix Biopharma AS for further development and commercialization efforts.
Symbol: VRCA
Recent Price: $0.70
Industry: Biotechnology
CEO: Mr. Ted White
Sector: Healthcare
Employees: 100
Address: 44 West Gay Street, West Chester, PA 19380
Phone: 484 453 3300
Last updated: 2024-12-31
Viridian Therapeutics, Inc.
VRDN-001, VRDN-002, VRDN-003
Viridian Therapeutics, Inc. is a biotechnology company focused on developing treatments for patients suffering from serious diseases, including thyroid eye disease.
Symbol: VRDN
Recent Price: $19.54
Industry: Biotechnology
CEO: Mr. Stephen F. Mahoney J.D., MBA
Sector: Healthcare
Employees: 94
Address: 221 Crescent Street, Waltham, MA 02453
Phone: 617 272 4600
Last updated: 2024-12-31
Virpax Pharmaceuticals, Inc.
Epoladerm, Probudur, Envelta, PES200, An Qlar, VRP324
Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company dedicated to developing drug-delivery systems and technologies for non-opioid, non-addictive pain management and treatments for central nervous system disorders.
Symbol: VRPX
Recent Price: $0.45
Industry: Biotechnology
CEO: Mr. Jatinder Dhaliwal
Sector: Healthcare
Employees: 7
Address: 1055 Westlakes Drive, Berwyn, PA 19312
Phone: 610 727 4597
Last updated: 2024-12-31
Verastem, Inc.
VS-6766
Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for cancer treatment, with products such as VS-6766 and trials like RAMP 201 and 202 targeting various cancer types.
Symbol: VSTM
Recent Price: $3.67
Industry: Biotechnology
CEO: Mr. Daniel W. Paterson
Sector: Healthcare
Employees: 73
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 781 292 4200
Last updated: 2024-12-31
Viatris Inc.
Prescription Brand Drugs, Generic Drugs, Complex Generic Drugs, Biosimilars, APIs
Viatris Inc. operates as a healthcare company worldwide, offering prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and APIs across various therapeutic areas, along with support services to help patients manage health.
Symbol: VTRS
Recent Price: $12.38
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Scott Andrew Smith
Sector: Healthcare
Employees: 33000
Address: 1000 Mylan Boulevard, Canonsburg, PA 15317
Phone: 724 514 1800
Last updated: 2024-12-31
X4 Pharmaceuticals, Inc.
mavorixafor
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.
Symbol: XFOR
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Paula Ragan Ph.D.
Sector: Healthcare
Employees: 127
Address: 61 North Beacon Street, Boston, MA 02134
Phone: 857 529 8300
Last updated: 2024-12-31
ZyVersa Therapeutics, Inc.
VAR 200 and IC 100
Zy Versa Therapeutics, Inc. is a clinical stage biopharmaceutical company developing products for renal and inflammatory diseases, including VAR 200 for focal segmental glomerulosclerosis and related conditions, and IC 100 as an ASC inhibitor for inflammatory diseases.
About | Vision/Values | Leadership | About | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About | About
Symbol: ZVSA
Recent Price: $1.07
Industry: Biotechnology
CEO: Mr. Stephen C. Glover
Sector: Healthcare
Employees: 7
Address: 2200 N. Commerce Parkway, Weston, FL 33326
Phone: 754 231 1688
Leadership
- Stephen C. Glover, Chairman of the Board at Ambrx Biopharma
- Pablo A. Guzman, MD, FACC, Board of Directors member
- Karen Cashmere, Board of Directors member
- Peter Wolfe, Board of Directors member
- Robert (Rob) G. Finizio, Executive Director of PleoPharma
- GREGORY G. FREITAG, JD, CPA, Principal of FreiMc
- Minchul Park, Ph.D, Chief Executive Officer, and Director of Curebio Therapeutics, Adjunct Professor, Korea University, Department of Pharmacy
- JAMES SAPIRSTEIN, Chairman, Chief Executive Officer and President of First Wave Biopharma
- N/A, N/A
Last updated: 2024-12-31
AbbVie Inc.
HUMIRA, SKYRIZI, RINVOQ, IMBRUVICA, VENCLEXTA, MAVYRET, CREON, Synthroid, Linzess/Constella, Lupron
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide, offering a range of therapies including HUMIRA for autoimmune diseases and MAVYRET for HCV infection.
About | ESG | News | Locations | Locations | Locations | Locations | Locations | Locations | Locations | Locations | Locations | Locations | Locations | Locations | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Jobs | Site Map | About | About | About | About | About | About | Jobs | Careers
Symbol: ABBV
Recent Price: $176.20
Industry: Drug Manufacturers - General
CEO: Mr. Robert A. Michael
Sector: Healthcare
Employees: 50000
Address: 1 North Waukegan Road, North Chicago, IL 60064-6400
Phone: 847 932 7900
Last updated: 2024-12-31
Theriva Biologics, Inc.
SYN-004, SYN-020, VCN-01
Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.
Symbol: TOVX
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Steven A. Shallcross CPA
Sector: Healthcare
Employees: 22
Address: 9605 Medical Center Drive, Rockville, MD 20850
Phone: 301 417 4364
Last updated: 2024-12-31
Ventyx Biosciences, Inc.
VTX958
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.
Symbol: VTYX
Recent Price: $2.23
Industry: Biotechnology
CEO: Dr. Raju S. Mohan Ph.D.
Sector: Healthcare
Employees: 73
Address: 662 Encinitas Boulevard, Encinitas, CA 92024
Phone: 760 593 4832
Last updated: 2024-12-31